User profiles for Maike Trommer
 | Maike TrommerRadiation Oncologist Verified email at uk-koeln.de Cited by 403 |
[HTML][HTML] Abscopal effects in radio-immunotherapy—Response analysis of metastatic cancer patients with progressive disease under anti-PD-1 immune checkpoint …
M Trommer, SY Yeo, T Persigehl, A Bunck… - Frontiers in …, 2019 - frontiersin.org
Immune checkpoint inhibition (ICI) targeting the programmed death receptor 1 (PD-1) has
shown promising results in the fight against cancer. Systemic anti-tumor reactions due to …
shown promising results in the fight against cancer. Systemic anti-tumor reactions due to …
Finanzielle Toxizität bei Krebspatient* innen unter Strahlentherapie
…, L Käsmann, M Sonnhoff, M Schneider, M Trommer… - Forum, 2022 - Springer
Hintergrund Krebspatient* innen können erheblichen finanziellen Belastungen ausgesetzt
sein. Vor diesem Hintergrund hat sich der Begriff der finanziellen Toxizität im Rahmen der …
sein. Vor diesem Hintergrund hat sich der Begriff der finanziellen Toxizität im Rahmen der …
[HTML][HTML] Oncologic outcome and immune responses of radiotherapy with anti-PD-1 treatment for brain metastases regarding timing and benefiting subgroups
M Trommer, A Adams, E Celik, J Fan, D Funken… - Cancers, 2022 - mdpi.com
Simple Summary Immune checkpoint inhibitors (ICIs) and radiotherapy (RT) are widely used
for patients with brain metastasis (BM). To evaluate markers for treatment response and find …
for patients with brain metastasis (BM). To evaluate markers for treatment response and find …
[HTML][HTML] First clinical experience with [68Ga] Ga-FAPI-46-PET/CT versus [18F] F-FDG PET/CT for nodal staging in cervical cancer
…, J Weindler, K Claus, P Linde, M Trommer… - Clinical Nuclear …, 2023 - journals.lww.com
All procedures performed in studies involving human participants were in accordance with
the ethical standards of the institutional and/or national research committee and with the 1964 …
the ethical standards of the institutional and/or national research committee and with the 1964 …
Potential synergy between radiotherapy and CAR T-cells-a multicentric analysis of the role of radiotherapy in the combination of CAR T cell therapy
…, G Goesmann, M Li, N Struve, M Trommer… - Radiotherapy and …, 2023 - Elsevier
Background Chimeric antigen receptor (CAR) T-cell therapy has improved the limited
overall survival (OS) of patients with intensively pretreated diffuse large B-cell lymphoma (DLBCL). …
overall survival (OS) of patients with intensively pretreated diffuse large B-cell lymphoma (DLBCL). …
Treatment monitoring of immunotherapy and targeted therapy using 18F-FET PET in patients with melanoma and lung cancer brain metastases: initial experiences
We investigated the value of O-(2- 18 F-fluoroethyl)-l-tyrosine ( 18 F-FET) PET for treatment
monitoring of immune checkpoint inhibition (ICI) or targeted therapy (TT) alone or in …
monitoring of immune checkpoint inhibition (ICI) or targeted therapy (TT) alone or in …
[HTML][HTML] Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin …
Background Despite the availability of effective systemic therapies, a significant number of
advanced melanoma patients develops brain metastases. This study investigated differences …
advanced melanoma patients develops brain metastases. This study investigated differences …
[HTML][HTML] Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a …
…, E Dippel, K Schatton, E Celik, M Trommer… - … for ImmunoTherapy of …, 2022 - ncbi.nlm.nih.gov
Background Despite of various therapeutic strategies, treatment of patients with melanoma
brain metastasis (MBM) still is a major challenge. This study aimed at investigating the impact …
brain metastasis (MBM) still is a major challenge. This study aimed at investigating the impact …
[HTML][HTML] Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancer
…, K Claus, P Linde, J Rosenbrock, M Trommer… - Radiation …, 2024 - Springer
Background Fibroblast activation protein (FAP) is expressed in the tumor microenvironment (TME)
of various cancers. In our analysis, we describe the impact of dual-tracer imaging with …
of various cancers. In our analysis, we describe the impact of dual-tracer imaging with …
[HTML][HTML] Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer–a first clinical approach
Background Expression of CXCR4, a chemokine (CXC motif) receptor that plays a central
role in tumor growth and metastasis of circulating tumor cells, has been described in a variety …
role in tumor growth and metastasis of circulating tumor cells, has been described in a variety …